As you will be aware, the Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of nivolumab for previously treated oesophageal cancer.
Please note that the timelines for this appraisal have been revised and the appraisal is now anticipated to begin in early December 2018.